Publications by authors named "U Munzel"

Claim this Profile
O
Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
Jean Bousquet, Eli O Meltzer, Peter Couroux, Arkady Koltun, Ferdinand Kopietz, Ullrich Munzel

J Allergy Clin Immunol Pract· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPLICATION OF ALTERNATIVE MINIMAL CLINICALLY IMPORTANT DIFFERENCE THRESHOLD ESTIMATION METHODS ON TECHNOLOGY ASSESSMENT.
Diana Brixner, Eli O Meltzer, Kellie Morland, Cathryn A Carroll, Ullrich Munzel

Int J Technol Assess Health Care· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.
Ludger Klimek, Claus Bachert, Ralph Mösges, Ullrich Munzel, David Price

Allergy Asthma Proc· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission.
L Kaskens, D Gehenio, U Munzel, J Darba

Value Health· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.
William E Berger, Shailen Shah, Phil Lieberman, James Hadley, David Price, Ullrich Munzel

J Allergy Clin Immunol Pract· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis